Targeting the androgen receptor (AR) in women with AR+ ER-/PR- metastatic breast cancer (MBC).
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Ayca Gucalp, Sara M. Tolaney, Steven J. Isakoff, James N. Ingle, Minetta C. Liu, Lisa A. Carey, Kimberly L. Blackwell, Hope S. Rugo, Lisle Nabell, Andres Forero-Torres, Vered Stearns, Lamia Momen, Joseph Gonzalez, Dilip D. Giri, Sujata Patil, Kimberly Feigin, Clifford Hudis, Tiffany A. Traina
Institutions: Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Massachusetts General Hospital, Mayo Clinic, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Duke Medical Center, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, University of Alabama at Birmingham, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2597278818